Journal of Food Science and Technology

, Volume 49, Issue 2, pp 173–183 | Cite as

Role of nutraceuticals in human health

  • Lipi Das
  • Eshani Bhaumik
  • Utpal Raychaudhuri
  • Runu ChakrabortyEmail author
Original Article


Nutraceutical is the hybrid of ‘nutrition’ and ‘pharmaceutical’. Nutraceuticals, in broad, are food or part of food playing a significant role in modifying and maintaining normal physiological function that maintains healthy human beings. The principal reasons for the growth of the nutraceutical market worldwide are the current population and the health trends. The food products used as nutraceuticals can be categorized as dietary fibre, prebiotics, probiotics, polyunsaturated fatty acids, antioxidants and other different types of herbal/ natural foods. These nutraceuticals help in combating some of the major health problems of the century such as obesity, cardiovascular diseases, cancer, osteoporosis, arthritis, diabetes, cholesterol etc. In whole, ‘nutraceutical’ has lead to the new era of medicine and health, in which the food industry has become a research oriented sector.


Dietary fiber Probiotics Prebiotics Polyphenols Spices Human diet 



This research work is financially supported by the Centre for Advanced Studies (CAS I) programme under University Grants Commission (UGC), India.


  1. Adelaja AO, Schilling BJ (1999) Nutraceutical: blurring the line between food and drugs in the twenty-first century. Mag Food Farm Resour Issues 14:35–40Google Scholar
  2. Albert CM, Campos H, Stampfer MJ, Ridker PM, Manson JE, Willett WC, Ma J (2002) Blood levels of long-chain n-3 fatty acids and the risk of sudden death. New Engl J Med 346:1113–1118CrossRefGoogle Scholar
  3. Ali M, Thomson M, Afzal M (2000) Garlic and onions: their effect on eicosanoid metabolism and its clinical relevance. Prostaglandins Leukot Essent Fatty Acids 6:55–73CrossRefGoogle Scholar
  4. Anderson JW, Randles KM, Kendall CWC, Jenkins DJA (2004) Carbohydrate and fiber recommendations for individuals with diabetes: a quantitative assessment and meta-analysis of the evidence. J Am Coll Nutr 23:5–17Google Scholar
  5. Anderson JW, Baird P, Davis RH Jr, Ferreri S, Knutdson M, Koraym A, Waters V, Williams CL (2009) Health benefits of dietary fibre. Nutr Rev 67:188–205CrossRefGoogle Scholar
  6. Argento A, Tiraferri E, Marzaloni M (2000) Oral anticoagulants and medicinal plants: an emerging interaction. Ann Ital Med Interna 15:139–143Google Scholar
  7. Bannerjee SK, Mukherjee PK, Maulik SK (2003) Garlic as an antioxidant: the good, the bad and the ugly. Phytother Res 17:97–106CrossRefGoogle Scholar
  8. Birketvedt GS, Shimshi M, Erling T, Florholmen J (2005) Experiences with three different fiber supplements in weight reduction. Med Sci Monit 11:15–18Google Scholar
  9. Broughton KS, Johnson CS, Pace BK, Liebman M, Kleppinger KM (1997) Reduced asthma symptoms with n-3 fatty acid ingestion are related to 5-series leukotriene production. Am J Clin Nutr 65:1011–1017Google Scholar
  10. Brower V (1998) Nutraceuticals: poised for a healthy slice of the healthcare market? Nat Biotechnol 16:728–731CrossRefGoogle Scholar
  11. Brown L, Rosner B, Willett WW, Sacks FM (1999) Cholesterollowering effects of dietary fiber: a meta-analysis. Am J Clin Nutr 69:30–42Google Scholar
  12. Buchner HC, Hengstler P, Schindler C, Meier G (2002) N-3 polyunsaturated fatty acids in coronary heart disease—a meta analysis of randomized controlled trials. Am J Med 112:298–304CrossRefGoogle Scholar
  13. Bull E (2000) What is nutraceutical? Pharm J 265:57–58Google Scholar
  14. Calabrese JR, Rappor DJ, Shelton MD (1999) Fish oils and bipolar disorder. Arch Gen Psychiatry 56:413–414 (commentary)CrossRefGoogle Scholar
  15. Carlson SE (1999) Long-chain polyunsaturated fatty acids and development of human infants. Acta Paediatr Suppl 88:72–77CrossRefGoogle Scholar
  16. Clark LC, Combs GF Jr, Turnbull BW, Slate EH, Chalker DK, Chow J, Davis LS, Glover RA, Graham GF, Gross EG, Kongrad A, Lesher JL, Park HK, Sanders BB, Smith CL, Taylor JR (1996) Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional prevention of cancer study group. J Am Med Assoc 276:1957–1963CrossRefGoogle Scholar
  17. Connor WE (2000) Importance of n-3 fatty acids in health and disease. Am J Clin Nutr 71(suppl):171S–175SGoogle Scholar
  18. Corder R, Douthwaite JA, Lees DM, Khan NQ, Santos AC, Wood EG, Carrier MJ (2001) Health: endothelin-1 synthesis reduced by red wine. Nature 414:863–864CrossRefGoogle Scholar
  19. Cummings JH (2001) The effect of dietary fiber on fecalweight and composition. In: Spiller G (ed) Dietary fiber in human nutrition. CRC Press, Boca Raton, pp 183–252CrossRefGoogle Scholar
  20. Dillard CJ, German JB (2000) Phytochemicals: nutraceuticals and human health. J Sci Food Agric 80:1744–1756CrossRefGoogle Scholar
  21. Doron S, Snydman DR, Gorbach SL (2005) Lactobacillus GG: bacteriology and clinical applications. Gastroenterol Clin North Am 34:483–498CrossRefGoogle Scholar
  22. Dureja H, Kaushik D, Kumar V (2003) Developments in nutraceuticals. Indian J Pharmacol 35:363–372Google Scholar
  23. Duthie GG, Gardner PT, Kyle JAM (2003) Plant polyphenols: are they the new magic bullet? Proc Nutr Soc 62:599–603CrossRefGoogle Scholar
  24. Edwards R, Peet M, Shay J, Horrobin D (1998) Omega-3 polyunsaturated fatty acid levels in the diet and in red blood cell membranes of depressed patients. J Affect Disord 48:149–155CrossRefGoogle Scholar
  25. Elliot JG (1999) Application of antioxidant vitamins in foods and beverages. Food Technol 53:46–48Google Scholar
  26. Ernst E (2003) Complementary medicine: where is the evidence? J Fam Pract 52:630–634Google Scholar
  27. Escott-Stump E, Mahan LK (2000) Krause’s food, nutrition and diet therapy, 10th edn. WB Saunders Company, Philadelphia, pp 553–559Google Scholar
  28. Food and Agricultural Org World Health Org 2001. Health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria.
  29. Fuller R (ed) (1992) Probiotics: the scientific basis. Chapman and Hall, LondonGoogle Scholar
  30. Gibson GR (1999) Dietary modulation of human gut microflora using the prebiotics Oligofructose and Inulin. J Nutr 129:1438S–1441SGoogle Scholar
  31. Gibson GR, Roberfroid MB (1995) Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr 125:1401–1412Google Scholar
  32. Gibson GR, Wang X (1994) Regulatory effects of bifidobacteria on other colonic bacteria. J Appl Bacteriol 77:412–420CrossRefGoogle Scholar
  33. Glore SR, Van Treeck D, Knehans A et al (1994) J Am Dent Assoc 94:425–436CrossRefGoogle Scholar
  34. Goldbohm RA, Hertog MGL, Brants HAM, van Poppel G, van den Brandt PA (1996) Consumption of black tea and cancer risk: a prospective cohort study. J Natl Cancer Inst 88:93–100CrossRefGoogle Scholar
  35. Goldhaber SB (2003) Trace element risk assessment: essentiality vs. toxicity. Regul Toxicol Pharmacol 38:232–242CrossRefGoogle Scholar
  36. Guarner F (2005) Inulin and oligofructose: impact on intestinal diseases and disorders. Br J Nutr 93(Suppl):S61–S65CrossRefGoogle Scholar
  37. Hathcock J (2001) Dietary supplements: how they are used and regulated. J Nutr 131:1114–1117Google Scholar
  38. Hendrich S, Lee K-W, Xu X, Wang HJ, Murphy PA (1994) Defining food components as new nutrients. J Nutr 124:1789s–1792sGoogle Scholar
  39. Hibbeln JR (1998) Fish consumption and major depression. Lancet 351:1213 (correspondence)CrossRefGoogle Scholar
  40. Hiroyasu I, Rexrode KM, Stampfer MJ, Manson JE, Colditz GA, Speizer FE, Hennekens CH, Willett WC (2001) Intake of fish and omega-3 fatty acids and risk of stroke in women. J Am Med Assoc 285:304–312CrossRefGoogle Scholar
  41. Hodge L, Salome CM, Peak JK, Haby MM, Xuan W, Woodlock AJ (1996) Consumption of oily fish and childhood asthma risk. Med J Aust 164:137–140Google Scholar
  42. Hord NG (2008) Eukaryotic microbiotic crosstalk: potential mechanisms for for health benefits of prebiotics and probiotics. Annu Rev Nutr 28:215–231CrossRefGoogle Scholar
  43. Institute of Medicine (2000) Food and Nutrition Board. Dietary reference intakes: vitamin C, vitamin E, selenium, and carotenoids. National Academy Press, Washington DCGoogle Scholar
  44. Institute of Medicine (2002) Dietary reference intakes for energy, carbohydrate, fibre, fat, fatty acids, cholesterol, protein and amino acidsGoogle Scholar
  45. Isolauri E, Juntunen M, Rautanen T, Sillanaukee P, Koivula T (1991) A human Lactobacillus strain (Lactobacillus casei sp. Strain GG) promotes recovery from acute diarrhea in children. Pediatrics 88:90–97Google Scholar
  46. John B (2001) Natural compounds in cancer therapy. Oregon Medical Press, PrincetonGoogle Scholar
  47. Kabara JJ (1991) Phenols and chelators. In: Russell NJ, Gould GW (eds) Food preservatives. Glasgow & London, Blackie, pp 200–214Google Scholar
  48. Kalia AN (2005) Textbook of Industrial Pharmacognocy, CBS publisher and distributor, New Delhi, pp 204–208Google Scholar
  49. Kaur C, Kapoor HC (2001) Antioxidants in fruits and vegetables-the millenium’s health. Int J Food Sci Technol 36:703–725CrossRefGoogle Scholar
  50. Keenan JM, Pins JJ, Frazel C, Moran A, Turnquist L (2002) Oat ingestion reduces systolic and diastolic blood pressure in patients with mild or borderline hypertension: a pilot trial. J Fam Pract 51:369–375Google Scholar
  51. Kochhar KP (2008) Dietary spices in health and diseases: I. Indian J Physiol Pharmacol 52:106–122Google Scholar
  52. Kohlmeier L, Simonsen N, Mottus K (1995) Dietary modifiers of Carcinogenesis. Environ Health Perspect 103:177–184Google Scholar
  53. Kokate CK, Purohit AP, Gokhale SB (2002) Nutraceutical and Cosmaceutical. Pharmacognosy, 21st edition, Pune, India: Nirali Prakashan, pp 542–549Google Scholar
  54. Kretchmer N (1994) Nutrition is the keystone of prevention (editorial). Am J Clin Nutr 60:1Google Scholar
  55. Lai PK, Roy J (2004) Antimicrobial and chemopreventive properties of herbs and spices. Curr Med Chem 11:1451–1460Google Scholar
  56. Lairon D, Arnault N, Bertrais S, Planells R, Clero E, Hercberg S, Boutron-Ruault M-C (2005) Dietary fiber intake and risk factors for cardiovascular disease in French adults. Am J Clin Nutr 82:1185–1194Google Scholar
  57. Lambert JD, Hong J, Yang G, Liao J, Yang CS (2005) Inhibition of carcinogenesis by polyphenols: evidence from laboratory investigations. Am J Clin Nutr 81(suppl):284S–291SGoogle Scholar
  58. Lampe JW (2003) Spicing up a vegetarian diet: chemopreventive effects of phytochemicals. Am J Clin Nutr 78:579S–583SGoogle Scholar
  59. Leclere CL, Champ M, Boillot J, Guille G, Lecannu G, Molis C, Bornet F, Krempff M, Delort-Laval J (1994) Role of viscous guar guam in lowering the glycemic response after a solid meal. Am J Nutr 59:914–921Google Scholar
  60. Lee J, Koo N, Min DB (2004) Reactive oxygen species, aging and antioxidative nutraceuticals. CRFSFS 3:21–33Google Scholar
  61. Lenoir-Wijnkoop I, Sanders ME, Cabana MD, Caglar E, Corthier G, Rayes N, Sherman PM, Timmerman HM (2007) Probiotic and prebiotic influence beyond the intestinal tract. Nutr Rev 65:469–89CrossRefGoogle Scholar
  62. Leray C, Wiesel ML, Freund M, Cazenave JP, Gachet J (2001) Long chain n-3 fatty acids specifically affect rat coagulation factors dependent on vitamin K: relation to peroxidative stress. Arterioscler Thromb Vasc Biol 21:459–465CrossRefGoogle Scholar
  63. Lin SY, Ayres JW, Wrinkler W, Sandine WE (1989) Lactobacillus effects on cholesterol: in-vitro and in-vivo results. J Dairy Sci 72:2885–2899CrossRefGoogle Scholar
  64. Liu S, Stampfer MJ, Hu FB et al (1999) Whole-grain consumption and risk of coronary heart disease: results from the Nurses’ Health study. Am J Clin Nutr 70:412–419Google Scholar
  65. Macfarlane S, Macfarlane GT, Cummings JH (2006) Review article: prebiotics in the gastrointestinal tract. Aliment Pharmacol Ther 24:701–714CrossRefGoogle Scholar
  66. Maddi VS, Aragade PD, Digge VG, Nitaliker MN (2007) Importance of nutraceuticals in health management. Phcog Rev 1:377–379Google Scholar
  67. Malik A (2008) The potentials of Nutraceuticals. 6Google Scholar
  68. Metchinkoff E (1907) The prolongation of life. Putmans Sons, New York, pp 151–183Google Scholar
  69. Meydani M (2000) Effect of functional food ingredients: vitamin E modulation of cardiovascular diseases and immune status in the elderly. Am J Clin Nutr 71:1665S–1668SGoogle Scholar
  70. Micallef M, Lexis L, Lewandowski P (2007) Red wine consumption increases antioxidant status and decreases oxidative stress in the circulation of both young and old humans. Nutrition J 6:27–34CrossRefGoogle Scholar
  71. Montonen J, Knekt P, Jarvinen R, Aromaa A, Reunanen A (2003) Whole-grain and fiber intake and the incidence of type 2 diabetes. Am J Clin Nutr 77:622–629Google Scholar
  72. Moskaug J, Carlsen H, Myhrstad Mari CW, Blomhoff R (2005) Polyphenols and glutathione synthesis regulation. Am J Clin Nutr 81(suppl):277S–283SGoogle Scholar
  73. Nadeau DA (1999) Oligosaccharides play important health role. The Soy Connection Interactive 7(3)Google Scholar
  74. Nemets B, Stahl Z, Bemaker RH (2002) Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder. Am J Psychiatr 159:477–479CrossRefGoogle Scholar
  75. Nicoli MC, Anese M, Parpinel M (1999) Influence of processing on the antioxidant properties of fruits and vegetables. Trends Food Sci Technol 10:94–100CrossRefGoogle Scholar
  76. Nutrition Business Journal, 1:2, September 1996Google Scholar
  77. Oboh G (2006) Antioxidant properties of some commonly consumed and underutilized tropical legumes. Eur Food Res Technol 224:61–65CrossRefGoogle Scholar
  78. Pandey M, Verma RK, Saraf SA (2010) Nutraceuticals:new era of medicine and health. Asian J Pharm Clin Res 3:11–15Google Scholar
  79. Pepping J (1999) Omega-3 essential fatty acids. Am J Health-Syst Pharm 56:719–724Google Scholar
  80. Petruzziello L, Iacopini F, Bulajic M, Shah S, Costamagna G (2006) Review article: uncomplicated diverticular disease of the colon. Aliment Pharmacol Ther 23:1379–1391CrossRefGoogle Scholar
  81. Pilch S (1987) Physiological effects and health consequences of dietary fibre. Bethesda, M.D.: Life Science Research Office. Federation of American Societies for Experimental BiologyGoogle Scholar
  82. Rao BN (2003) Bioactive Phytochemicals in Indian foods and their potential in health promotion and disease prevention. Asia Pac J Clin Nutr 12:9–22Google Scholar
  83. Rice-Evans CA, Miller NJ, Paganga G (1997) Antioxidant properties of phenolic compounds. Trends Plant Sci Rev 2:152–159CrossRefGoogle Scholar
  84. Rishi RK (2006) Nutraceuticals: borderline between food and drug? Pharma Rev 51–53Google Scholar
  85. Sahu SC (2002) Dual role of organosulfur compounds in foods: a review. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 20:61–76Google Scholar
  86. Saibil F (1989) Diarrhea due to fiber overload. New Engl J Med 320:599Google Scholar
  87. Sami Labs—pioneer in nutraceuticals Aug 05, 2002. The Hindu Newspaper; Avaliable from:
  88. Sanders ME (1994) Lactic acid bacteria as promoters of human health. In: Goldberg I (ed) Functional foods: designer foods, pharmafoods and nutraceuticals. Chapman & Hall, London, pp 294–322Google Scholar
  89. Sato M, Maulik N, Das D (2002) Cardioprotection with alcohol: role of both alcohol and polyphenolic antioxidants. Ann NY Acad Sci 957:122–135CrossRefGoogle Scholar
  90. Scalbert A, Johnson IT, Saltmarsh M (2005) Polyphenols: antioxidants and beyond. Am J Clin Nutr 81(suppl):215S–217SGoogle Scholar
  91. Schrezenmeir J, de Vrese M (2001) Probiotics, prebiotics, and synbiotics—approaching a definition. Am J Clin Nutr 73:316S–364SGoogle Scholar
  92. Simopoulos A (1991) Omega-3 fatty acids in health and disease and in growth and development. Am J Clin Nutr 54:438–463Google Scholar
  93. Sreejayan R, Rao MNA (1994) Curcuminoids as potent inhibitors of lipid peroxidation. J Pharm Pharmacol 46:1013–1016CrossRefGoogle Scholar
  94. Steffen LM, Jacobs DR Jr, Stevens J, Shahar E, Carithers T, Folsom AR (2003) Associations of whole-grain, refined grain, and fruit and vegetable consumption with risks of all-cause mortality and incident coronary artery disease and ischemic stroke: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Clin Nutr 78:383–390Google Scholar
  95. Steiner M, Khan AH, Holbert D, Lin RIS (1996) A double-blinded crossover study in moderately hypercholesterolemic men that compared the effect of aged garlic extracts and placebo administration on blood lipids. Am J Clin Nutr 64:866–870Google Scholar
  96. Stoll AL, Severus WE, Freeman MP, Rueter S, Zboyan HA, Diamond E, Cress KK, Marangell LB (1999) Omega 3 fatty acids in bipolar disorder. A preliminary double-blind, placebo-controlled trial. Arch Gen Psych 56:407–412 and pp 415–416 (commentary)Google Scholar
  97. Stranges S, Marshall JR, Trevisan M, Natarajan R, Donahue RP, Combs GF, Farinaro E, Clark CL, Reid ME (2006) Effects of selenium supplementation on cardiovascular disease incidence and mortality: secondary analyses in a randomized clinical trial. Am J Epidemiol 163:694–699CrossRefGoogle Scholar
  98. Suvarna VC, Boby VU (2005) Probiotics in human health: a current assessment. Curr Sci 88:1744–1748Google Scholar
  99. Tinggi U (2007) Selenium: its role as antioxidant in human health. Environ Health Prev Med 13:102–108CrossRefGoogle Scholar
  100. United States Food and Drug Administration. September 8, 2004. FDA announces qualified health claims for omega-3-fatty acids. Press ReleaseGoogle Scholar
  101. Watkins TR, Bierenbaurn MI, Giampalala A (1999) Tocotrienols: biological and health effects. In: Papas AM (ed) Antioxidant status, diet, nutrition and health. CRC Press, Boca Raton, pp 479–496Google Scholar
  102. Watzl B, Girrbach S, Roller M (2005) Inulin, oligofructose and immunomodulation. Br J Nutr 93(Suppl 1):S49–S55CrossRefGoogle Scholar
  103. Whelton SP, Hyre AD, Pedersen B, Yi Y, Whelton PK, He J (2005) Effect of dietary fiber intake on blood pressure: a metaanalysis of randomized, controlled clinical trials. J Hypertens 23:475–481CrossRefGoogle Scholar
  104. Wildman REC (ed) (2001) Handbook of nutraceuticals and functional foods. CRC Press, Boca Raton, pp 13–30Google Scholar
  105. Yang G, Wang ZY, Kim S, Liao J, Seril DN, Chen X, Smith TJ, Yang CS (1997) Characterization of early pulmonary hyperproliferation and tumor progression and their inhibition by black tea in a 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis model with A/J mice. Cancer Res 57:1889–1894. Evolving nutraceuticalGoogle Scholar
  106. Yang CS, Landau JM, Huang MT, Newmark HL (2001) Inhibition of carcinogenesis by dietary polyphenolic compounds. Annu Rev Nutr 21:381–406CrossRefGoogle Scholar

Copyright information

© Association of Food Scientists & Technologists (India) 2011

Authors and Affiliations

  • Lipi Das
    • 1
  • Eshani Bhaumik
    • 1
  • Utpal Raychaudhuri
    • 1
  • Runu Chakraborty
    • 1
    Email author
  1. 1.Department of Food Technology and Biochemical EngineeringJadavpur UniversityKolkataIndia

Personalised recommendations